Versatech / Impyrian Technology Network LLC

Versatech / Impyrian Technology Network LLC, doing business as V-Ten, operates as a prime contractor delivering audiovisual systems design, installation, technical support, and IT services to the Food and Drug Administration under an 8(a) sole-source indefinite delivery contract and holds a position on the GSA 8(a) STARS III government-wide IT services GWAC. V-Ten is an SBA Certified 8(a) Joint Venture, small disadvantaged business, and Black American-owned limited liability company headquartered in Fulton, Maryland, competing exclusively under the 8(a) set-aside framework and operating 100% as a prime contractor with no subcontract role.

The FDA dominates V-Ten's customer footprint. Of 28 total prime awards in the source portfolio, 26 are FDA delivery orders representing $142.3 million in combined potential value — nearly all issued under V-Ten's $99.92 million single-award indefinite delivery contract established September 9, 2022, and running through April 27, 2028. The remaining two awards consist of a $2.9 million Cyber Security Support Services delivery order from the Office of the Chief Financial Officer under the 8(a) STARS III GWAC (awarded March 17, 2025) and V-Ten's seat on the 8(a) STARS III itself ($50 billion multiple-award GWAC awarded February 23, 2022, with completion July 1, 2026). The concentration is extreme: the FDA's combined potential value of $142.3 million plus the GWAC's $50 billion placeholder ceiling mean that the ranking by count (FDA-heavy) and by potential value (dominated by the GWAC placeholder) diverge sharply — but the GWAC ceiling is a system placeholder, and active task-order volume anchors to FDA operations.

Across SCI-reportable federal service contracts, V-Ten invoiced $4.9 million in FY2024 on nine prime contracts, delivering roughly 32.6 FTEs. Government-paid hourly rates ranged from a 10th percentile of $64.19/hr to a median of $69.17/hr, with specialized labor such as program management reaching $213.23/hr at the 90th percentile. V-Ten self-performed all reported labor on these contracts with zero subcontractor hours, indicating a vertically integrated delivery model for its core AV and support-services work. FY2023 and FY2025 show no SCI-reported invoicing, likely reflecting timing between award and performance phases or the difference between contract ceiling and actual billing.

Capability work centers on comprehensive audiovisual infrastructure across FDA's Washington, D.C. metropolitan-area campuses. Representative FDA delivery orders include a $12.4 million time-and-materials contract for White Oak campus OFEMS (Office for Facilities, Equipment and Management Services) AV support services awarded September 19, 2023; a $7.3 million labor-hour virtual meeting support services order for White Oak awarded September 20, 2023; a $3.6 million time-and-materials contract for Center for Drug Evaluation and Research AV support services awarded September 4, 2024; a $2.5 million audiovisual improvements order for FDA Building 66 at White Oak awarded September 21, 2026; and smaller conference-room upgrades, equipment installations, and technical maintenance across FDA facilities in Silver Spring, Takoma Park, Berwyn Heights, and Derwood, Maryland. The recent September 2026 awards cluster (five orders totaling approximately $3.5 million) signals active expansion of FDA delivery orders under the existing IDV. On the GWAC, V-Ten's single task order to date carries firm fixed-price cybersecurity support services — a capability expansion beyond AV infrastructure.

V-Ten faces a recompete cliff of 12 awards (combined potential value $30 million) with ultimate completion dates inside the next twenty-four months, driven by FY2027 and FY2028 expiration dates on multiple FDA OFEMS, virtual meeting, program management, and facility-upgrade delivery orders. The underlying FDA IDV itself extends through April 27, 2028, providing continued vehicle authority for new task orders; however, the concentration of delivery-order completions in FY2027–FY2028 will force recompete cycles on those specific scope areas. The SBA 8(a) Joint Venture certification carries a historical expiration date of August 18, 2023, recorded in the source — if not actively renewed, it would represent compliance risk for future 8(a) set-aside awards, though the source documents active awards issued after that nominal expiration, suggesting the certification remains current or has been extended outside the source capture window.